HIV-related ototoxicity

Seminars in Hearing

Volumn 19, Issue 2, 1998, Pages 155-161

  Bankaitis, Aukse E ^a   Schountz, Tony ^b  

^a S LOUIS UNIV HLTH SCIENCES CENTER   (United States)

^b OAK RIDGE NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPHOTERICIN B; ANTIFUNGAL AGENT; ANTIMYCOBACTERIAL AGENT; ANTINEOPLASTIC AGENT; ANTIRETROVIRUS AGENT; BLEOMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; CLOFAZIMINE; CLOTRIMAZOLE; CYCLOSPORIN; DIDANOSINE; FLUCONAZOLE; FLUCYTOSINE; GENTAMICIN; INDINAVIR; ITRACONAZOLE; KETOCONAZOLE; KYNOSTATIN 272; LAMIVUDINE; METRONIDAZOLE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; UNINDEXED DRUG; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BLOOD TOXICITY; HEARING LOSS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER TOXICITY; NEPHROTOXICITY; NEUROTOXICITY; OPPORTUNISTIC INFECTION; OTALGIA; OTOTOXICITY; REVIEW; TINNITUS; VERTIGO; VESTIBULAR DISORDER;

EID: 0031922735     PISSN: 07340451     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0028-1082965     Document Type: Review

References (27)

1. Abbas, A.K., Lichtman, A.H., & Pober, J.S. (1994). Cellular and Molecular Immunology (2nd ed). Philadelphia: Saunders
2. ARIC (1996a). ARIC's AIDS medical glossary on-line: Phases (of clinical trials). [On-line]. Available: http://www.critpath.org/aric/ gloss/phases.htm
3. ARIC (1996b). ARIC's AIDS medical glossary on-line: Nucleoside analogue. [On-line]. Available: http://www.critpath.org/aric/gloss/ nucleoside_analogue.htm
4. Autran, B., Carcelain, G., Li, T.S., Blanc, C., Mathez, D., Tubiana, R., Katlama, C., Debre, P., & Leibowitch, J. (1997). Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science, 277, 112
5. Bankaitis, A.E. (1996). Audiological changes attributable to HIV-infection. Audiology Today, 8(6), 14-16
6. Blaschke, T.F., Nies, A.S., & Mamelok, R.D. (1995). Principles of therapeutics. In A.G. Gilman, L.S. Goodman, and Rall, T.W. (Eds.), Goodman and Gilman's The Pharmacological Basis of Therapeutics (7th ed.) (pp. 49-65). New York: Macmillan
7. Cohen, J. (1997). The Daunting challenge of keeping HIV suppressed. Science, 277, 32
8. Dean, M., Carrington, M., Winkler, C., Huttley, G.A., Smith, M.W., Allikmets, R., Goedertt, J.J., Buchbinder, S.P., Vittinghoff, E., Gomperts, E., Donfiled, S., Vlahov, D., Kaslow, R., Saah, S., Rinaldo, C., & Detels, R., (1996). Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science, 273, 1856
9. Fan, H., Connor, R., & Villarreal, L. (1991). The biology of AIDS. Boston, MA: Jones and Bartlett Publishers
10. Gallo, R.C., & Montagnier, L. (1988). Aids in 1988. Scientific America, 259, 41
11. Greene, W.C. (1991). The molecular biology of human immunodeficiency virus type 1 infection. New England Journal of Medicine, 324, 308
12. Greene, W.C. (1993). AIDS and the immune system, Scientific American, September, 99-105
13. Katz, R.A., & Skalka, A.M. (1994). The retroviral enzymes. Annual Review of Biochemistry, 63, 133
14. Kearney, B. (1995). The HIV drug book. New York: Pocket Books
15. Lalwani, A.K., & Sooy, C.D. (1992). Otologic and neurologic manifestations of acquired immunodeficiency syndrome. The Otolaryngological Clinics of North America, 25(6), 1183-1198
16. McMichael, A.J., & Phillips, R.E. (1997). Escape of human immunodeficiency virus from immune control. Annual Reviews of Immunology, 15, 271
17. National Institute of Allergy and Infectious Disease. (October, 1993) Backgrounder. Bethesda, MD: Office of Communication, National Institutes of Health, U.S. Department of Health and Human Services
18. Pataleo, G., Graziosi, C., Butini, L., Pizzo, P.A., Schnittman, S.M., Kotler, D.P., & Fauci, A.S. (1991). Lymphoid organs function as major reservoirs for human immunodeficiency virus. Proceedings of the National Academy of Science, 88, 9838
19. Physician's desk reference (1998). Medical Economics Co., Inc. Montvale, NJ
20. Project Inform (1995). Project inform fact sheet. Antiviral medications: Antivirals A to Z. [On-line]. Available: http://www.projinf.org/fs/ anti-a2z.html
21. Project Inform (1996). Project inform protease inhibitors fact sheet. [On-line]. Available: http://www.projinf.org/fs/protease.html
22. Rosenberg, Z.F., & Fauci, A.S. (1989). The immunopathogenesis of HIV infection. Advances in Immunology, 47, 377
23. Scott, A. (1987). Pirates of the cell: The story of viruses from molecule to microbe. Oxford: Blackwell
24. Shipp, K.W., & Nabors, K.L. (1993). The role of the pharmacists in the care of patients with HIV infection. In J.A. Bartlett (Ed.), Care and Management of Patients with HIV Infection. Research Triangle Park, NC: Glaxo, Inc
25. Varmus, H. (1988). Retroviruses. Science, 240, 1427
26. Wlodawer, A., & Erickson, J.W. (1993). Structure-based inhibitors of HIV-1 protease. Annual Review of Biochemistry, 62, 543
27. Yarchoan, R., Mitsuya, H., & Broder, S. (1993). Challenges in the therapy of HIV infection. Immunology Today, 14, 303